 | Up a level |
Hoepner, Robert; Bagnoud, Maud; Pistor, Maximilian; Salmen, Anke; Briner, Myriam; Synn, Helen; Schrewe, Lisa; Guse, Kirsten; Ahmadi, Farhad; Demir, Seray; Laverick, Louis; Gresle, Melissa; Worley, Paul; Reichardt, Holger Michael; Butzkueven, Helmut; Gold, Ralf; Metz, Imke; Lühder, Fred; Chan, Andrew (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta neuropathologica, 138(3), pp. 443-456. Springer-Verlag 10.1007/s00401-019-02018-8
Miclea, Andrei; Salmen, Anke; Wiest, Roland; Zoehner, Greta; Wagner, Franca; Hoepner, Andreas; Schrewe, Lisa; Evangelopoulos, Maria-Eleptheria; Kamber, Nicole; Chan, Andrew Hao-Kuang; Hoepner, Robert (2019). Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study. Therapeutic advances in neurological disorders, 12, p. 1756286419835652. Sage 10.1177/1756286419835652
Evangelopoulos, Maria Eleftheria; Miclea, Andrei; Schrewe, Lisa; Briner, Myriam; Salmen, Anke; Engelhardt, Britta; Huwiler, Andrea; Chan, Andrew; Hoepner, Robert (2018). Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod. CNS neuroscience & therapeutics, 24(10), pp. 984-986. Wiley 10.1111/cns.12992
Pistor, Maximilian; Schrewe, Lisa; Haupeltshofer, Steffen; Miclea, Andrei; Faissner, Simon; Chan, Andrew; Hoepner, Robert (2018). 1,25-OH vitamin D and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL). Leukemia research reports, 9, pp. 38-41. Elsevier 10.1016/j.lrr.2018.01.003
Ambrosius, Björn; Pitarokoili, Kalliopi; Schrewe, Lisa; Pedreiturria, Xiomara; Motte, Jeremias; Gold, Ralf (2017). Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection. Journal of neuroinflammation, 14(1), p. 92. BioMed Central 10.1186/s12974-017-0864-z
